AVERY BARNHILL: Open Payments
NPI 1861124240 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,573 in 28 payments from 12 companies in 2025. Trend: 2023 $116 · 2024 $745 · 2025 $1,573
Food & beverage: $1,573
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 4 | $444 |
| Abbott Laboratories | 4 | $195 |
| Dexcom, Inc. | 2 | $192 |
| E.R. Squibb & Sons, L.L.C. | 6 | $137 |
| BioMarin Pharmaceutical Inc. | 1 | $134 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Insulet Corporation | 1 | $104 |
| AstraZeneca Pharmaceuticals LP | 1 | $93 |
| Boston Scientific Corporation | 4 | $66 |
| BridgeBio Pharma, Inc. | 2 | $38 |
Products named: Barostim Neo System, Dexcom G6 Transmitter, CAMZYOS, VOXZOGO 1.2mg, VOQUEZNA, AVEIR, OMNIPOD, LOKELMA.
Industry payments across TX — which companies pay providers there.
